154 related articles for article (PubMed ID: 23092068)
21. A case of heavy chain disease: diagnosis and monitoring using assays of immunoglobulin heavy and light chains.
Mitchell PE; Ford RP; Coughtrie MW; Heppleston AD; Fraser CG
Scott Med J; 1990 Feb; 35(1):18-9. PubMed ID: 2107572
[TBL] [Abstract][Full Text] [Related]
22. Analysis of patients with γ-heavy chain disease by the heavy/light chain and free light chain assays.
Kaleta E; Kyle R; Clark R; Katzmann J
Clin Chem Lab Med; 2014 May; 52(5):665-9. PubMed ID: 24327529
[TBL] [Abstract][Full Text] [Related]
23. Gamma-heavy chain monoclonal gammopathy with undetermined significance (MGUS).
Zushi Y; Sasaki M; Saitoh T; Aoyama Y; Gotoh Y; Tsunemine H; Kodaka T; Okamura A; Takahashi T
J Clin Exp Hematop; 2019 Sep; 59(3):119-123. PubMed ID: 31391403
[TBL] [Abstract][Full Text] [Related]
24. [An unusual case of heavy gamma-chain disease with several monoclonal components: IgG kappa, IgM lambda, Bence-Jones proteins kappa and lambda].
Chernokhvostova EV; German GP; Varlamova EIu; Andreeva NE; Kotova TS
Ter Arkh; 1991; 63(7):80-5. PubMed ID: 1788816
[No Abstract] [Full Text] [Related]
25. Long-term renal survival of γ3-heavy chain deposition disease: a case report.
Katsuno T; Mizuno S; Mabuchi M; Tsuboi N; Komatsuda A; Maruyama S
BMC Nephrol; 2017 Jul; 18(1):239. PubMed ID: 28716013
[TBL] [Abstract][Full Text] [Related]
26. A patient with severe renal amyloidosis associated with an immunoglobulin gamma-heavy chain fragment.
Yazaki M; Fushimi T; Tokuda T; Kametani F; Yamamoto K; Matsuda M; Shimojo H; Hoshii Y; Higuchi K; Ikeda S
Am J Kidney Dis; 2004 May; 43(5):e23-8. PubMed ID: 15112195
[TBL] [Abstract][Full Text] [Related]
27. Heavy chain disease.
Witzig TE; Wahner-Roedler DL
Curr Treat Options Oncol; 2002 Jun; 3(3):247-54. PubMed ID: 12057070
[TBL] [Abstract][Full Text] [Related]
28. Gamma heavy chain disease complicated by pulmonary hypertension, which was successfully treated with lenalidomide.
Shibata S; Fukunaga A
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33257362
[TBL] [Abstract][Full Text] [Related]
29. Unusual sequence of immunoglobulin L-chain rearrangements in a gamma heavy chain disease patient.
Hauke G; Schiltz E; Bross KJ; Hollmann A; Peter HH; Krawinkel U
Scand J Immunol; 1992 Sep; 36(3):463-8. PubMed ID: 1519038
[TBL] [Abstract][Full Text] [Related]
30. Tubulointerstitial nephritis accompanying gamma-heavy chain deposition and gamma-heavy chain restricted plasma cells in the kidney.
Nayer A; Green DF; Gonzalez-Suarez ML; Sujoy V; Ikpatt OF; Thomas DB
Iran J Kidney Dis; 2014 Sep; 8(5):417-23. PubMed ID: 25194410
[TBL] [Abstract][Full Text] [Related]
31. A case of mu heavy-chain disease associated with hyperglobulinemia, anemia, and a positive Coombs test.
Witzens M; Egerer G; Stahl D; Werle E; Goldschmidt H; Haas R
Ann Hematol; 1998 Nov; 77(5):231-4. PubMed ID: 9858149
[TBL] [Abstract][Full Text] [Related]
32. Deleted IgG1 and IgG2 H chains in a patient with an IgG subclass imbalance.
Lebreton JP; Fontaine M; Rousseaux J; Youinou P; Hurez D; Rivat-Peran L; Bernards JP
Clin Exp Immunol; 1982 Jan; 47(1):206-16. PubMed ID: 6807588
[TBL] [Abstract][Full Text] [Related]
33. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C
Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425
[TBL] [Abstract][Full Text] [Related]
34. Mu-heavy chain disease: presentation as a benign monoclonal gammopathy.
Wahner-Roedler DL; Kyle RA
Am J Hematol; 1992 May; 40(1):56-60. PubMed ID: 1566748
[TBL] [Abstract][Full Text] [Related]
35. [Biological difficulties of a heavy chains disease diagnosis].
Planté P; Hochart AC; Gressier B
Ann Biol Clin (Paris); 2022 Feb; 80(1):75-79. PubMed ID: 35107066
[TBL] [Abstract][Full Text] [Related]
36. Gamma Heavy Chain Disease - Diagnostic Challenges in an Unusual Case and a Brief Synopsis of the Current Literature.
Mrosewski I; Urbank M
Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013371
[TBL] [Abstract][Full Text] [Related]
37. Chronic arthritis and gamma heavy chain disease: coincidence or pathogenic link?
Husby G; Blichfeldt P; Brinch L; Brandtzaeg P; Mellbye OJ; Sletten K; Stenstad T
Scand J Rheumatol; 1998; 27(4):257-64. PubMed ID: 9751465
[TBL] [Abstract][Full Text] [Related]
38. A unique case of γ-heavy chain deposition disease characterized by concomitant deposition of γ2 and γ4 subclasses.
Yin G; Wu Y; Zeng CH; Chen HP; Liu ZH
Intern Med; 2014; 53(22):2615-8. PubMed ID: 25400185
[TBL] [Abstract][Full Text] [Related]
39. A case report: isolated a heavy chain monoclonal gammopathy in a patient with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin change syndrome.
Kim SK; Park IK; Park BH; Park W; Lee HS; Kim TH; Jun JB; Bae SC; Yoo DH; Uhm WS
Int J Clin Pract Suppl; 2005 Apr; (147):26-30. PubMed ID: 15875614
[TBL] [Abstract][Full Text] [Related]
40. A case of gamma 3 heavy chain disease with vacuolated plasma cells: a clinical, immunological, and ultrastructural study.
Feremans W; Caudron M; Bieva C
J Clin Pathol; 1979 Apr; 32(4):334-43. PubMed ID: 109474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
